A Global Network of Specialized CDMOs and Enabling Technologies

Our Mission

Helping Improve the Health of Humankind.

At Ajinomoto Bio-Pharma Services, our mission is to help improve the health of humankind by advancing manufacturing and development solutions that enable our partners to bring therapies to patients around the world.

That mission comes to life through the expertise of our teams, the technologies we develop, and the way we work with partners to move important programs forward.

What Defines Us

Our Shared Foundation

Across our specialized capabilities and technologies, our shared pillars shape how we work, how we partner, and how we turn complex therapies into manufacturable solutions.

Scientific Innovation

We apply deep scientific knowledge and decades of technical progress to help turn complex ideas into meaningful therapeutic solutions.

Specialized Expertise

Our specialized CDMO capabilities and enabling technologies are backed by the deep modality expertise required to advance novel and complex therapies.

Rigorous Quality Commitment

Across our global network, quality guides how we work, from compliance and safety to continuous improvement and trusted delivery.

Operational Excellence

We bring agile systems, reliable execution, and collaborative problem-solving together to help move programs forward with confidence.

Sustainability

We advance platforms, processes, and practices that support progress while reducing environmental impact across operations and delivery.

Global by Scale. Specialized by Design.

With locations in the United States, Belgium, India, and Japan, we integrate a global infrastructure with the precision of dedicated specialists to deliver adaptive solutions and responsive service across evolving program needs.

CDMO Services & Platform Technologies

Alongside our CDMO services, our proprietary platform technologies provide purpose-built approaches to development and manufacturing challenges.

CDMO Services

Specialized development and manufacturing services across small molecules, oligonucleotides, peptides, gene therapies, proteins, and bioconjugates.

Platform Technologies

AJICAP™ Site-Specific Conjugation and Linker Technology

AJIPHASE™ Oligonucleotide and Peptide Manufacturing

CORYNEX™ Recombinant Protein and Peptide Expression

Contributing to the well-being of all people, our society, and our planet

The Ajinomoto Group is guided by a commitment to creating social and economic value through its businesses, with scientific discovery, responsibility, and long-term impact at the center of that approach. We are proud to be part of that broader purpose.

More Than 100 Years of Unlocking Innovation

Top view green forest with globe earth. Sustainable Environment concept. Carbon reduction emissions target. Green energy is eco-friendly. Save Earth or World Earth Day Concept. Environmental Care

Innovating for a More Sustainable Future

We continue to advance technologies, processes, and operational practices designed to reduce environmental impact while supporting efficient, reliable development and manufacturing. Sustainability shapes how we approach innovation, operations, and planning for the future.

Meet the leaders guiding Ajinomoto Bio-Pharma Services across our global network.

Let’s turn shared purpose into meaningful progress.